Champix (varenicline tartrate tablets) 0.5mg; 1mg (Varenicline Tartrate Tablets) Drug Instructions, Dosage and Clinical Data

Basic information

Drug category type

0.5 mg；1.0 mg

Specification

0.5mg；1mg

Standard dose

Clinical Decision · Pharmacological Treatment for Smoking Cessation in Adults

Approval number

Execution standard

<p>Imported Drug Registration Standard JX20190269</p>

Shelf life

Product information

Description

This product is a white to off-white film-coated tablet (0.5 mg strength) or a light blue film-coated tablet (1.0 mg strength), appearing white after removal of the coating.

Storage

Store sealed below 25 ℃.

Packaging

Shelf life

Execution standard

<p>Imported Drug Registration Standard JX20190269</p>

Approval number

Approval date

Modified date

Category path

Level 1 categoryOther Nervous System Drugs

Level 2 categoryMedications for Pathological Addiction

Level 3 categoryDrugs for Nicotine Dependence

Level 4 category—

Ingredients

The main active ingredient of this product is varenicline tartrate. Chemical name: 7,8,9,10-tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine-(2R,3R)-2,3-dihydroxybutanedioate (1:1) Chemical structural formula: Molecular formula: C13H13N3·C4H6O6 Molecular weight: 361.36 Excipients: microcrystalline cellulose, anhydrous dibasic calcium phosphate, croscarmellose sodium, colloidal silicon dioxide, magnesium stearate, Opadry® White (for 0.5 mg strength), Opadry Blue (for 1.0 mg strength), Opadry Clear.

Related recommendations

Medicine Data Sources

See how SinoMDB organizes medicine information from public regulatory records, clinical medication references, and drug interaction materials.

View data source notes